Table 1.
Baseline characteristics of all patients
| Number | n (< 18 years) | n (≥ 18 years) | Sex (m/f) | Age (years) | BMI (kg/m2)a | |
|---|---|---|---|---|---|---|
| Total | 932 | 294 | 638 | 486/446 (52.1%/47.9%) | 68 (3; 81) | 25.7 (22.6; 29.8) |
| SARS-CoV-2 | 493 (52.9%) | 63 (21.4%) | 430 (67.4%) | 267/226 (54.2%/45.8%) | 77 (61; 84)* | 25.9 (22.6; 29.5) |
| Influenza A | 216 (23.2%) | 53 (18.0%) | 163 (25.5%) | 108/108 (50.0%/50.0%) | 65 (20; 78)* | 25.5 (22.9; 31.5) |
| Influenza B | 1 (0.1%) | 0 (0.0%) | 1 (0.2%) | 1/0 (100%/0%) | n.d | n.d |
| RSV | 203 (21.8%) | 168 (57.1%) | 35 (5.5%) | 101/102 (49.8%/50.2%) | 1 (0; 3)* | 23.6 (20.7; 26.5) |
| Influenza A + SARS | 6 (0.6%) | 1 (0.3%) | 5 (0.8%) | 4/2 (66.7%/33.3%) | 82 (58; 83) | 21.4 (20.0; 30.1) |
| Influenza A + RSV | 8 (0.9%) | 5 (1.7%) | 3 (0.5%) | 2/6 (25.0%/75.0%) | 3.5 (0.8; 72) | n.d |
| Influenza B + RSV | 1 (0.1%) | 1 (0.3%) | 0 (0%) | 1/0 (100%/0%) | n.d | n.d |
| SARS + RSV | 4 (0.4%) | 3 (1.0%) | 1 (0.2%) | 2/2 (50%/50%) | 2.0 (0.3; 56) | n.d |
Numbers and percentages, or median values and quartiles (in parentheses) are given
n.d., not determined; BMI, body mass index
*significantly different from each other (p < 0.001)
aAvailable only in patients of age ≥ 18 years